Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19
Research article
[키워드] analyzed
antibody
Biomarker
Case series
cerebrospinal fluid
chemokine
chemokines
children
children with COVID-19
clinical
clinical manifestation
Control
controls
coronavirus
correlated
COVID-19
CSF
cytokine
Cytokines
described
discharge
electrochemiluminescence assay
elevated
Encephalopathy
FIVE
full-length
High-dose
IFN-γ
IL-1β
IL-2
IL-8
Immunotherapy
Inflammatory
intravenous
laboratory-confirmed
mechanism
MIG
MIP-1β
MIS-C
N-terminal domain
Neuroinflammation
Neuropsychiatric
occur
one patient
outcome
pathophysiologic
Patient
pediatric
pediatric COVID-19
Pediatric patient
pro-inflammatory
profile
Psychiatric
Psychiatric symptoms
Receptor binding domain
required
Result
retrospective
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
Seizures
significantly
steroid
Steroids
student
Symptom
Symptoms
syndrome
t-test
tested
TNF-α
Tocilizumab
Treatment
with COVID-19
[DOI] 10.1016/j.msard.2021.103169 [Article Type] Research article
[DOI] 10.1016/j.msard.2021.103169 [Article Type] Research article